The Billion-Dollar Molecule: The Quest for the Perfect Drug - Barry Werth

Descriere YEO:

The Billion-Dollar Molecule: The Quest - Disponibil la libris.ro

Pe YEO găsești The Billion-Dollar Molecule: The Quest de la Barry Werth, în categoria Business & Economics.

Indiferent de nevoile tale, The Billion-Dollar Molecule: The Quest for the Perfect Drug - Barry Werth din categoria Business & Economics îți poate aduce un echilibru perfect între calitate și preț, cu avantaje practice și moderne.

Preț: 111.6 Lei

Caracteristicile produsului The Billion-Dollar Molecule: The Quest

• Brand: Barry Werth
• Categoria: Business & Economics
• Magazin: libris.ro
• Ultima actualizare: 13-11-2024 01:34:21

Comandă The Billion-Dollar Molecule: The Quest Online, Simplu și Rapid

Prin intermediul platformei YEO, poți comanda The Billion-Dollar Molecule: The Quest de la libris.ro rapid și în siguranță. Bucură-te de o experiență de cumpărături online optimizată și descoperă cele mai bune oferte actualizate constant.

Descriere magazin:
This inside account of Vertex, a start-up pharmaceutical company, conveys the exciting drama being played out in the pioneering and enormously profitable field of drug research. Vertex is dedicated to designing--atom by atom--a new life-saving immunosuppressant drug that has major implications for HIV research. Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing -- atom by atom -- both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.